The New York Times considered how the official end of the GLP-1 shortages is affecting patients —...
The story this past Monday is one of the best media reports on compounding that we’ve seen. The patient and provider they feature are almost as good as Joe. Almost. And of course we’re thrilled that the reporter drew from APC’s briefing on compounded GLP-1s and thus gets not only the story but the terminology right.
The New York Times considered how the official end of the GLP-1 shortages is affecting patients —...
Stat News covered the fact that “Dozens of attorneys general urge FDA to crack down on counterfeit...
Reuters, like many other media outlets, covered Novo Nordisk’s request that the FDA add semaglutide...